About Trevarx Biomedical
Trevarx Biomedical is a private company based in Philadelphia, Pennsylvania. It has reported $1,500,000 raised in three offerings on Form D since August 2019. Its chief executive is Jean Cho.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jul 25, 2025 | Aug 4, 2025 | $350,000of $750K target | 6 | $58,333 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Sep 15, 2022 | Sep 20, 2022 | $500,000fully sold | 10 | $50,000 | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jul 24, 2019 | Aug 8, 2019 | $650,000of $850K target | 11 | $59,091 | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $1,500,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Trevarx Biomedical's Form D filed Aug 4, 2025.
JC
Jean Cho
Chief Executive Officer and director